CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $961,466 | +302.3% | 195,818 | +647.0% | 0.00% | +300.0% |
| Q2 2022 | $239,000 | +35.8% | 26,215 | +81.4% | 0.00% | – |
| Q4 2021 | $176,000 | -12.4% | 14,449 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $201,000 | -13.4% | 13,000 | +21.9% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | -41.6% | 10,664 | -65.9% | 0.00% | -80.0% |
| Q3 2020 | $397,000 | +168.2% | 31,231 | +179.0% | 0.01% | +25.0% |
| Q1 2020 | $148,000 | -78.3% | 11,195 | -73.5% | 0.00% | 0.0% |
| Q4 2019 | $681,000 | +258.4% | 42,254 | +306.4% | 0.00% | +100.0% |
| Q3 2019 | $190,000 | -19.1% | 10,397 | +6.2% | 0.00% | -33.3% |
| Q3 2018 | $235,000 | -78.3% | 9,794 | -88.9% | 0.00% | -84.2% |
| Q4 2017 | $1,084,000 | +32.2% | 88,566 | +0.3% | 0.02% | -44.1% |
| Q4 2016 | $820,000 | – | 88,279 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |